Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer Meeting Abstract


Authors: Goto, K.; Oxnard, G.; Tan, D. S. W.; Loong, H. H. F.; Bauer, T.; Gainor, J.; McCoach, C.; Gautschi, O.; Besse, B.; Cho, B. C.; Peled, N.; Weiss, J.; Kim, Y. J.; Ohe, Y.; Horiike, A.; Park, K.; Huang, X.; Olek, E.; Subbiah, V.; Drilon, A.
Abstract Title: Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small-cell lung cancer
Meeting Title: 2020 Swiss Oncology and Hematology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 150
Issue: Suppl. 247
Meeting Dates: 2020 Nov 18-21
Meeting Location: Virtual
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2020-11-17
Start Page: 7 S
Language: English
ACCESSION: WOS:000592781900012
PROVIDER: wos
PUBMED: 33200807
DOI: 10.4414/smw.2020.20411
Notes: Meeting Abstract: O11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon